Kingsview Wealth Management LLC Acquires New Shares in Nutrien Ltd. $NTR

Key Points

• Kingsview Wealth Management acquired 16,247 Nutrien shares worth approximately $1.02 million, while institutional investors collectively own 63.1% of the company.
• Nutrien reported quarterly EPS of $2.61, below the $2.70 consensus estimate, despite revenue of $10.81 billion exceeding expectations; year-over-year revenue increased 3.6%.
• The company declared a quarterly dividend of $0.55, equivalent to $2.20 annually and a 3.0% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $81.58 versus the stock’s $73.64 price.

Kingsview Wealth Management LLC purchased a new stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 16,247 shares of the company's stock, valued at approximately $1,023,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Wellington Management Group LLP increased its position in Nutrien by 440.2% during the fourth quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company's stock worth $1,008,713,000 after buying an additional 13,313,817 shares during the last quarter. First Eagle Investment Management LLC increased its holdings in shares of Nutrien by 0.5% during the 4th quarter. First Eagle Investment Management LLC now owns 13,307,283 shares of the company's stock valued at $821,326,000 after acquiring an additional 70,068 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Nutrien by 2.0% in the 4th quarter. Deutsche Bank AG now owns 9,798,196 shares of the company's stock valued at $604,745,000 after acquiring an additional 189,683 shares in the last quarter. TD Asset Management Inc lifted its holdings in Nutrien by 21.2% in the 4th quarter. TD Asset Management Inc now owns 8,928,534 shares of the company's stock worth $551,821,000 after purchasing an additional 1,559,673 shares during the last quarter. Finally, Mackenzie Financial Corp boosted its position in Nutrien by 4.4% during the fourth quarter. Mackenzie Financial Corp now owns 7,219,733 shares of the company's stock worth $450,310,000 after purchasing an additional 305,458 shares during the period. Institutional investors and hedge funds own 63.10% of the company's stock.

Nutrien Stock Up 0.8%

NYSE NTR opened at $73.64 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The firm has a 50-day simple moving average of $67.33 and a 200 day simple moving average of $70.56. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36. The stock has a market cap of $35.23 billion, a PE ratio of 14.91, a PEG ratio of 0.78 and a beta of 0.61.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.70 by ($0.09). The firm had revenue of $10.81 billion for the quarter, compared to the consensus estimate of $10.44 billion. Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The company's revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.65 earnings per share. On average, research analysts forecast that Nutrien Ltd. will post 4.71 EPS for the current year.

Nutrien Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date is Tuesday, September 29th. Nutrien's dividend payout ratio is presently 44.53%.

Key Stories Impacting Nutrien

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
• Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
• Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
• Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Wall Street Analysts Forecast Growth

NTR has been the topic of several analyst reports. Canadian Imperial Bank of Commerce reiterated an "outperform" rating on shares of Nutrien in a report on Monday, August 10th. Mizuho dropped their price objective on Nutrien from $77.00 to $75.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 14th. Morgan Stanley cut their price objective on Nutrien from $93.00 to $81.00 and set an "overweight" rating for the company in a research report on Tuesday, July 7th. UBS Group lowered their target price on Nutrien from $67.00 to $65.00 and set a "sell" rating on the stock in a report on Monday, May 11th. Finally, Wall Street Zen downgraded Nutrien from a "buy" rating to a "hold" rating in a research report on Saturday, May 16th. Seventeen investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Nutrien presently has a consensus rating of "Moderate Buy" and an average target price of $81.58.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source